Skip to Content

← See all Motion Sickness brands

Motion Sickness by ARMY AND AIR FORCE EXCHANGE SERVICE

Dosage form: tablet
Ingredients: MECLIZINE HYDROCHLORIDE 25mg
Labeler: ARMY AND AIR FORCE EXCHANGE SERVICE
NDC Code: 55301-403

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Exchange Select 44-403

Active ingredient (in each tablet)

Meclizine HCl 25 mg

Purpose

 Antiemetic

Uses

for the prevention and treatment of nausea, vomiting, or dizziness associated with motion sickness 

Warnings

Do not use

 for children under 12 years of age unless directed by a doctor

Ask a doctor before use if you have
  • glaucoma
  • difficulty in urination due to enlargement of the prostate gland
  • a breathing problem such as emphysema or chronic bronchitis 

Ask a doctor or pharmacist before use if you are

 taking sedatives or tranquilizers.

When using this product
  • drowsiness may occur
  • avoid alcoholic beverages
  • alcohol, sedatives, and tranquilizers may increase drowsiness
  • use caution when driving a motor vehicle or operating machinery 

If pregnant or breast-feeding,

 ask a health professional before use.

Keep out of reach of children.

 In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Directions
  • to prevent motion sickness, take the first dose one hour before starting activity
  • to prevent or treat motion sickness: 1 to 2 tablets once daily for adults and children 12 years and over, or as directed by a doctor 

Other information
  • TAMPER EVIDENT: DO NOT USE IF OUTER PACKAGE IS OPENED OR BLISTER IS TORN OR BROKEN 
  • store at 25ºC (77ºF); excursions permitted between 15º-30ºC (59º-86ºF)
  • protect from heat and humidity
  • see end flap for expiration date and lot number

Inactive ingredients

corn starch, D&C yellow #10 aluminum lake, lactose, magnesium stearate, silica gel

Questions of comments?

1-800-426-9391

Principal Display Panel

exchange √ select

Compare to The Active Ingredient of
Dramamine® Less Drowsy Formula*

LESS DROWSY FORMULA
MOTION SICKNESS
Meclizine HCl Tablets 25mg / Antiemetic

Helps prevent Nausea and Dizziness due to
Motion Sickness for up to 24 hours

16
TABLETS
Actual Size

quality value

*This product is not manufactured or distributed by Prestige Brands, Inc., owner of the registered trademark Dramamine® Less Drowsy Formula.
50844        REV0715J40321

"SATISFACTION GUARANTEED OR YOUR MONEY BACK"
Manufactured For Your Military Exchanges
Distributed by: LNK International, Inc.
Hauppauge, NY 11788
1-800-426-9391

TAMPER EVIDENT: DO NOT USE IF PACKAGE IS OPENED OR IF BLISTER UNIT IS TORN, BROKEN OR SHOWS ANY SIGNS OF TAMPERING

Exchange Select 44-403

MOTION SICKNESS 
meclizine hcl tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:55301-403
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MECLIZINE HYDROCHLORIDE (MECLIZINE) MECLIZINE HYDROCHLORIDE25 mg
Inactive Ingredients
Ingredient NameStrength
D&C YELLOW NO. 10 
MAGNESIUM STEARATE 
STARCH, CORN 
SILICON DIOXIDE 
LACTOSE, UNSPECIFIED FORM 
Product Characteristics
ColorYELLOWScoreno score
ShapeROUNDSize9mm
FlavorImprint Code44;403
Contains    
Packaging
#Item CodePackage Description
1NDC:55301-403-212 BLISTER PACK in 1 CARTON
18 TABLET in 1 BLISTER PACK
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH FINALpart33606/24/2002
Labeler - ARMY AND AIR FORCE EXCHANGE SERVICE (001695568)
Establishment
NameAddressID/FEIOperations
LNK International, Inc.038154464PACK(55301-403)
Establishment
NameAddressID/FEIOperations
LNK International, Inc.832867894MANUFACTURE(55301-403)
Establishment
NameAddressID/FEIOperations
LNK International, Inc.832867837PACK(55301-403)

 
ARMY AND AIR FORCE EXCHANGE SERVICE

← See all Motion Sickness brands

Medically reviewed on Feb 24, 2017

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide